Balasa Dinverno & Foltz LLC Abiomed Inc Transaction History

Balasa Dinverno & Foltz LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 06, 2019	SELL	$175.89 - $279.23 $199,283 - $316,367	-1,133 Closed	0 $0
Q2 2019 Aug 07, 2019	SELL	$250.96 - $284.94 $192,988 - $219,118	-769 Reduced 40.43%	1,133 $295,000
Q1 2019 May 10, 2019	SELL	$276.39 - $362.25 $93,419 - $122,440	-338 Reduced 15.09%	1,902 $543,000
Q4 2018 Feb 04, 2019	SELL	$281.08 - $444.25 $104,280 - $164,816	-371 Reduced 14.21%	2,240 $728,000
Q3 2018 Oct 24, 2018	SELL	$354.53 - $449.75 $12,763 - $16,191	-36 Reduced 1.36%	2,611 $1.17 Million
Q2 2018 Aug 01, 2018	BUY	$278.07 - $446.21 $65,346 - $104,859	235 Added 9.74%	2,647 $1.08 Million
Q1 2018 Apr 23, 2018	BUY	$192.49 - $295.85 $34,648 - $53,253	180 Added 8.06%	2,412 $702,000
Q4 2017 Feb 05, 2018	SELL	$168.78 - $199.74 $22,616 - $26,765	-134 Reduced 5.66%	2,232 $418,000
Q3 2017 Oct 18, 2017	BUY	$145.39 - $168.6 $343,992 - $398,907	2,366	2,366 $399,000

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Balasa Dinverno & Foltz LLC, based on Form 13F filings with the SEC.

Stay updated on Balasa Dinverno & Foltz LLC with notifications on news.